Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study-Reference-Cited by-同舟云学术

Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study

Published:2016-10 Issue:10 Volume:101 Page:3779-3786
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Souma Nao,Isakova Tamara,Lipiszko David,Sacco Ralph L.,Elkind Mitchell S. V.,DeRosa Janet T.,Silverberg Shonni J.,Mendez Armando J.,Dong Chuanhui,Wright Clinton B.,Wolf Myles

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia;Clinical and Experimental Nephrology;2024-02-25

2. Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI;Journal of the American Society of Nephrology;2024-01-04

3. Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study;Kidney Medicine;2023-11

4. Elevated morbidity and mortality in patients with chronic idiopathic hypophosphatemia: a nationwide cohort study;Frontiers in Endocrinology;2023-08-10

5. Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction—results from the augsburg myocardial infarction registry;Frontiers in Cardiovascular Medicine;2023-08-04